Develops drugs for ovarian cancer.
Dec 2025Revenue $0.00/yrExpenses $153M/yr
No trendCash runway ≈ 1.4 years from Jun 2026
Figures by year
When will Zentalis Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $153M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $153M | −$153M |
| Dec 2024 | $67.4M | $259M | −$191M |
| Dec 2023 | $0.00 | $300M | −$300M |
| Dec 2022 | $0.00 | $227M | −$227M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.